Project Grant HT94252510298
Award Date
4/15/25
Completion Date
4/14/28
Dollars Obligated
$650K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Defense Health Agency awarded a $1,695,794 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to develop a state-of-the-art microbur-driven non-absorbable epithelial SERT antagonist to treat anxiety and depression in military members and the general public. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports basic, applied, and advanced biomedical research to...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides funding of $1,493,233.00 to The Trustees of Columbia University in the City of New York to conduct research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award period is from November 15, 2024 to November 14, 2027. The research seeks to develop innovative approaches to prevent, diagnose, and...
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, received a $567,654 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This funding supports spatial profiling of early, osimertinib-resistant brain lesions in EGFR-mutant lung cancer models over the 2-year period from July 1, 2023 to June 30, 2025. Through this grant, Columbia University will conduct biomedical research...
The Department of the Army Medical Command awarded a $2,056,250 Project Grant to The Trustees of Columbia University in the City of New York, through the Military Medical Research and Development program (CFDA 12.420), to support research on "Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery." This 3-year grant, running from Sep 1, 2024 to Aug 31, 2027, will enable advanced biomedical research initiatives focused on transforming healthcare for military service...
The Defense Health Agency has awarded a $860,998.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding will support a 3-year research project focused on "NEUROPHYSIOLOGY OF POST-TRAUMATIC EPILEPSY: UNRAVELING EPILEPTOGENESIS SIGNALS BIOMARKERS", with a performance period from April 1, 2025 to March 31, 2028. The research aims to advance the scientific...
The federal Project Grant award for "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $707,436 award to the Albert Einstein College of Medicine, a private non-profit educational institution, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The grant...
The Trustees of Columbia University in the City of New York (Columbia University) was awarded a $658,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 targeting inflammatory signals as therapeutic strategies for peripheral T-cell lymphoma. Through this award, Columbia University will investigate medical solutions for lymphoma, a type of cancer...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $822,501.00 to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to conduct research on "Restoring GABAergic Inhibition as a Potential Therapy for TSC-Associated Neurocognitive Impairment." The project, which has a performance period from May 1, 2025 to April 30,...
The federal Project Grant award, with ID HT94252510096, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The $197,400.00 award supports the "DEVELOPMENT OF PATIENT-DERIVED CNS METASTASIS MODELS WITH STK11 INACTIVATION FOR DRUG DISCOVERY" at The Trustees of Columbia University in the City of New York, in New York, NY. The project aims to develop patient-derived central nervous system (CNS) metastasis...
This $199,115.92 federal Project Grant award was issued on May 15, 2024 by the U.S. Department of Defense Research Development and Engineering Command (RDECOM) under the Basic Scientific Research program (CFDA 12.431). The award supports foundational and applied research across a broad spectrum of scientific and technical domains, with the goal of advancing fundamental knowledge and developing capabilities with potential military applications. The grant recipient is The Trustees of Columbia...